Cargando…
Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation
INTRODUCTION: This study aimed to predict the dose absorbed by normal organs with neuroendocrine tumors for (131)I using single photon emission computed tomography/computed tomography (SPECT/CT) images and Geant4 application for tomographic emission (GATE) simulation. MATERIALS AND METHODS: Four to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481846/ https://www.ncbi.nlm.nih.gov/pubmed/34658551 http://dx.doi.org/10.4103/ijnm.ijnm_6_21 |
_version_ | 1784576772183949312 |
---|---|
author | Asl, Rohollah Ghahraman Sabbaghi, Rezvan Ahangari, Hadi Taleshi Hejazi, Payman Foroutan, Majid |
author_facet | Asl, Rohollah Ghahraman Sabbaghi, Rezvan Ahangari, Hadi Taleshi Hejazi, Payman Foroutan, Majid |
author_sort | Asl, Rohollah Ghahraman |
collection | PubMed |
description | INTRODUCTION: This study aimed to predict the dose absorbed by normal organs with neuroendocrine tumors for (131)I using single photon emission computed tomography/computed tomography (SPECT/CT) images and Geant4 application for tomographic emission (GATE) simulation. MATERIALS AND METHODS: Four to 5 whole-body planar scan series, along with one SPECT/CT image, were taken from four patients following (99m)Tc-hynic-Tyr(3)-octreotide radiotracer injection. After image quantification, the residence time of each organ was calculated using the image analysis and the activity time curves. The energy deposit and dose conversion (S-value) were extracted from the GATE simulation for the target organs of each patient. Using the residence times and S-values, the mean absorbed dose for the target organs of each patient was calculated and compared with the data obtained from the standard method. RESULTS: Very close agreement was obtained between the S-value of the self–organ irradiation. The mean percentage difference between the two methods (i.e. GATE and Medical Internal Radiation Dose [MIRD]) was 1.8%, while a weak agreement was observed for cross-organ irradiation. The percentage difference between the total absorbed doses by the organs was 2%. The percentage difference between the absorbed doses obtained for tumors and three considered normal organs estimated by the GATE method was slightly higher than the MIRD method (about 11% on average for tumors). CONCLUSION: Regardless of the small difference between the obtained results for the organs and absorbed doses of the tumors in the present study, patient-specific dosimetry by the GATE methods is useful and essential for therapeutic radionuclides such as (131)I due to high cross-dose effects, especially for young adult patients, to ensure the radiation safety and increase the effectiveness of the treatment. |
format | Online Article Text |
id | pubmed-8481846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-84818462021-10-14 Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation Asl, Rohollah Ghahraman Sabbaghi, Rezvan Ahangari, Hadi Taleshi Hejazi, Payman Foroutan, Majid Indian J Nucl Med Original Article INTRODUCTION: This study aimed to predict the dose absorbed by normal organs with neuroendocrine tumors for (131)I using single photon emission computed tomography/computed tomography (SPECT/CT) images and Geant4 application for tomographic emission (GATE) simulation. MATERIALS AND METHODS: Four to 5 whole-body planar scan series, along with one SPECT/CT image, were taken from four patients following (99m)Tc-hynic-Tyr(3)-octreotide radiotracer injection. After image quantification, the residence time of each organ was calculated using the image analysis and the activity time curves. The energy deposit and dose conversion (S-value) were extracted from the GATE simulation for the target organs of each patient. Using the residence times and S-values, the mean absorbed dose for the target organs of each patient was calculated and compared with the data obtained from the standard method. RESULTS: Very close agreement was obtained between the S-value of the self–organ irradiation. The mean percentage difference between the two methods (i.e. GATE and Medical Internal Radiation Dose [MIRD]) was 1.8%, while a weak agreement was observed for cross-organ irradiation. The percentage difference between the total absorbed doses by the organs was 2%. The percentage difference between the absorbed doses obtained for tumors and three considered normal organs estimated by the GATE method was slightly higher than the MIRD method (about 11% on average for tumors). CONCLUSION: Regardless of the small difference between the obtained results for the organs and absorbed doses of the tumors in the present study, patient-specific dosimetry by the GATE methods is useful and essential for therapeutic radionuclides such as (131)I due to high cross-dose effects, especially for young adult patients, to ensure the radiation safety and increase the effectiveness of the treatment. Medknow Publications & Media Pvt Ltd 2021 2021-09-23 /pmc/articles/PMC8481846/ /pubmed/34658551 http://dx.doi.org/10.4103/ijnm.ijnm_6_21 Text en Copyright: © 2021 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Asl, Rohollah Ghahraman Sabbaghi, Rezvan Ahangari, Hadi Taleshi Hejazi, Payman Foroutan, Majid Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation |
title | Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation |
title_full | Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation |
title_fullStr | Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation |
title_full_unstemmed | Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation |
title_short | Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation |
title_sort | prediction of absorbed dose to normal organs with endocrine tumors for i-131 by use of (99m)tc single photon emission computed tomography/computed tomography and geant4 application for tomographic emission simulation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481846/ https://www.ncbi.nlm.nih.gov/pubmed/34658551 http://dx.doi.org/10.4103/ijnm.ijnm_6_21 |
work_keys_str_mv | AT aslrohollahghahraman predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation AT sabbaghirezvan predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation AT ahangarihaditaleshi predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation AT hejazipayman predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation AT foroutanmajid predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation |